Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Bellato, Federica (2019) Targeting dendritic cells with mannosylated cationic glycopolymers for nucleic acid-mediated cancer immunotherapy. [Ph.D. thesis]

Full text disponibile come:

[img]PDF Document (Tesi di dottorato) - Accepted Version
Thesis not accessible until 03 December 2022 for intellectual property related reasons.
Visibile to: nobody

4Mb

Abstract (italian or english)

Tumour immunology has been changing the landscape of modern medicine and anticancer therapy, by developing a variety of tumor antigenic peptide-based and nucleic acid-based treatments. Among the several nucleic acid-based therapeutics developed so far, short single-stranded synthetic DNA (ssDNA) molecules, known as CpG oligodeoxynucleotides (ODNs), was found to stimulate B cells and plasmacytoid dendritic cells (pDCs) and activate both innate and adaptative immune responses, thus raising interest for infectious diseases, cancers, and allergy treatment.1 Furthermore, delivery of pDNA or mRNA encoding Tumor Associated Antigens (TAAs) to Dendritic Cells (DCs) is an emerging and promising alternative to the delivery of the parent antigenic peptide for antitumor vaccination, because they have shown to be safer and to provide a higher protein expression upon internalization by Antigen Presenting Cells (APCs).2 Nucleic acids uptake by APCs results in the translation in antigens that are presented through the Major Histocompatibility Complex (MHC) to the immune system cells. This strategy allows to trigger both a direct immune response and a long-term memory against cancer cells. To date, lipid-based systems and viral vectors have dominated the nucleic acid delivery scenario. However, recently synthetic positively charged polymeric carriers have drawn increasing attention, since they provide opportunities for improved safety, greater flexibility and more facile manufacturing while preventing the enzymatic degradation of genetic material and mediating its cellular uptake. The specific term “polyplex” has been coined to identify the supramolecular structures derived from the electrostatic interactions between those polymers and nucleic acids.
In this PhD project, Reversible Addition Fragmentation chain Transfer (RAFT) polymerization3 has been exploited for the synthesis of two generations of diblock and triblock copolymers designed to deliver pDNA encoding TAAs to antigen presenting cells and to trigger the direct immune response and a long-term memory against cancer. The 1st generation of these novel materials was designed with a poly-cationic agmatine acrylamide block to condense oligonucleotides, and with a mannosylated block to actively and selectively target Mannose Receptor (MR)4 expressed on DCs. Furthermore, a 2nd generation of polymers was further engineered by adding a butyl acrylate-based hydrophobic block with the aim of enhancing the endosomal escape properties of this family of carriers. A small library of three cationic di-block copolymers (Man15-b-Agm12, Man29-b-Agm25 and Man58-b-Agm45) and two tri-block copolymers (Man29-b-Agm29-b-But9 and Man62-b-Agm52-b-But32) was obtained via fast RAFT polymerization using D-Mannose acrylamide (Man), Agmatine acrylamide (Agm), and butyl acrylate (But) as monomers. Polymers were generated using identical monomer feed ratios but increasing total monomers units (corresponding to different final polymer molecular weights) to elucidate the effect of the polymer length on nucleic acids complexation and delivery to cells, and glycopolyplexes (GPPs) stability.
Initially, a short single strand DNA (ssDNA, 19 bases) as model for CpG ODN, was used to generate the GPPs. The optimum nitrogen to phosphate (N/P) ratio to achieve complete ssDNA complexation was evaluated by gel electrophoresis. Furthermore, DLS and TEM characterization confirmed the assembly and the narrow size distribution in the range of 25-55 nm, which was maintained over time also in the presence of serum proteins. The strong electrostatic interactions between polymers and ssDNA were confirmed by the Zeta potential reduction of 4-11 mV for 1st generation and of 11-18 mV for the 2nd generation polymers after ssDNA complexation. The association strength and the stability of polymers/ssDNA glycopolyplexes was investigated by the heparin displacement assay. All tested systems required a concentration of heparin at least 6-fold higher than its physiological concentration in the blood (0.15 IU/mL) to induce total ssDNA displacement, with di-block co-polymers retaining ssDNA more strongly as compared to the tri-blocks. Furthermore, polymers ability to cause red blood cells lysis ex vivo was correlated with their potential to induce endosomal membrane disruption. Particularly, the capacity of the butyl acrylate-based hydrophobic portion to induce endosomolysis under early endosomes mimicking conditions (pH 6) was confirmed by the higher percentage of induced hemolysis for Man29-b-Agm29-b-But9 and Man62-b-Agm52-b-But32 respect to 1st generation polymers. However, a good compromise between biocompatibility and endosomolytic activity of our systems was confirmed by in vitro viability assay performed with the polyplexes in the polymer concentrations range 0.005-0.2 mg/mL. In vitro uptake studies were performed either on model cell lines CHO (Chinese hamster ovary cells, wild type) and CHO-MR+ (Mannose Receptor expressing CHO cells) or on immortalized dendritic cells DC2.4. The internalization of glycopolyplexes loaded with Cy3-ssDNA was evaluated by flow cytometry after 30 minutes or 1 hour of incubation with cells. As expected, a certain degree of selectivity in the recognition of mannose receptor-expressing cells by the GPPs was observed after 30 minutes of incubation, with the 1st generation low molecular weights polymers outperforming (around 4.5-fold increase in the uptake with respect to free ssDNA) the high molecular weight (2.5-fold increase in the uptake with respect to free ssDNA) and the butyl block-bearing polymers (1.5-fold increase in the uptake with respect to free ssDNA).
The successful complexation and delivery of high molecular weight nucleic acid by the glycopolymers was a key for transfection capabilities. 1st and 2nd generation glycopolymers were used to complex a model plasmid DNA encoding Enhanced Green Fluorescent Protein (pEGFP, 4759 bp). Agarose gel electrophoresis showed that all glycopolymers form stable complexes with pEGFP at relatively low N/P ratios of 5 for Man15-b-Agm12/pEGFP and Man29-b-Agm25/pEGFP, and 2.5 for Man58-b-Agm45/pEGFP, Man29-b-Agm29-b-But9/pEGFP and Man62-b-Agm52-b-But32/pEGFP. The stability of the systems in presence of poly-anionic competitive agents was also investigated, showing the release of pDNA at 1 IU/mL heparin concentration, which is 6-fold above its physiological concentration. The DLS and TEM analysis of the resulting GPPs showed the presence of mixed rod- and toroidal- shaped complexes with a size in the range 100-1000 nm. Moreover, in vitro transfection efficiency was evaluated on both CHO/CHO-MR+ and immortalized dendritic cell lines at a selected nitrogen to phosphorous ratio for each polymer. Flow cytometry and confocal microscopy pointed out that Man29-b-Agm29-b-But9/pEGFP, Man62-b-Agm52-b-But32/pEGFP and Man58-b-Agm45/pEGFP complexes yielded the best transfection performance. In light of these evidences, these materials were selected for further investigation on dendritic cells, using plasmid encoding full-length ovalbumin (pOVA), a well-known immunogenic protein, to trigger an in vitro immune response against it. The immunological studies highlighted that the expression on DCs of the costimulatory clusters of differentiation CD86, necessary for T cell activation, was increased by cell incubation with Man58-b-Agm45/pOVA and Man62-b-Agm52-b-But32/pOVA GPPs. Furthermore, these two GPPs were found to induce a slightly higher presentation of the SIINFEKL ovalbumin antigenic epitope by MHC I complex with respect to free pOVA and Man29-b-Agm29-b-But9/pOVA. Finally, these two polymeric platforms were tested in vivo on C57BL/6 mice bearing B16-OVA melanoma tumor to investigate the applicability of these novel systems in the anticancer immunotherapy field. Both prophylactic and therapeutic approaches showed a higher efficacy of Man58-b-Agm45/pOVA in comparison to Man62-b-Agm52-b-But32/pOVA GPPs in controlling the tumor growth or reducing the tumor volume. In addition, immunological analysis on tumor and spleen samples showed a high level of specific activation of T cells against SIINFEKL antigenic peptide only in samples derived from mice treated with Man58-b-Agm45/pOVA, confirming it as a promising candidate for cancer vaccination.


EPrint type:Ph.D. thesis
Tutor:Salmaso, Stefano
Supervisor:Mastrotto, Francesca
Ph.D. course:Ciclo 32 > Corsi 32 > SCIENZE MOLECOLARI > SCIENZE FARMACEUTICHE
Data di deposito della tesi:02 December 2019
Anno di Pubblicazione:30 September 2019
Key Words:immunotherapy, gene delivery, anticancer vaccination, block co-polymers
Settori scientifico-disciplinari MIUR:Area 03 - Scienze chimiche > CHIM/09 Farmaceutico tecnologico applicativo
Area 03 - Scienze chimiche > CHIM/08 Chimica farmaceutica
Struttura di riferimento:Dipartimenti > Dipartimento di Scienze del Farmaco
Codice ID:12307
Depositato il:02 Feb 2021 10:45
Simple Metadata
Full Metadata
EndNote Format

Bibliografia

I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Hanagata, N. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. International journal of nanomedicine 7, 2181 (2012). Cerca con Google

2. Khan, K.H. DNA vaccines: roles against diseases. Germs 3, 26 (2013). Cerca con Google

3. Moad, G., Rizzardo, E. & Thang, S.H. Radical addition–fragmentation chemistry in polymer synthesis. Polymer 49, 1079-1131 (2008). Cerca con Google

4. Keler, T., Ramakrishna, V. & Fanger, M.W. Mannose receptor-targeted vaccines. Expert opinion on biological therapy 4, 1953-1962 (2004). Cerca con Google

5. Ragelle, H., Danhier, F., Préat, V., Langer, R. & Anderson, D.G. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opinion on Drug Delivery 14, 851-864 (2017). Cerca con Google

6. Li, Z., Tan, S., Li, S., Shen, Q. & Wang, K. Cancer drug delivery in the nano era: An overview and perspectives. Oncology reports 38, 611-624 (2017). Cerca con Google

7. Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. cell 100, 57-70 (2000). Cerca con Google

8. Hanahan, D. & Weinberg, R.A. Hallmarks of cancer: the next generation. cell 144, 646-674 (2011). Cerca con Google

9. Chen, D.S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1-10 (2013). Cerca con Google

10. Moura, L.I., et al. Functionalized Branched Polymers: Promising Immunomodulatory Tools for the Treatment of Cancer and Immune Disorders. Materials Horizons (2019). Cerca con Google

11. Vanneman, M. & Dranoff, G. Combining immunotherapy and targeted therapies in cancer treatment. Nature reviews cancer 12, 237 (2012). Cerca con Google

12. Barenholz, Y.C. Doxil®—the first FDA-approved nano-drug: lessons learned. Journal of controlled release 160, 117-134 (2012). Cerca con Google

13. Autio, K.A., et al. Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial. JAMA oncology 4, 1344-1351 (2018). Cerca con Google

14. Couzin-Frankel, J. Cancer immunotherapy. (American Association for the Advancement of Science, 2013). Cerca con Google

15. Coley, W.B. The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proceedings of the Royal Society of Medicine 3, 1-48 (1910). Cerca con Google

16. Khalil, D.N., Smith, E.L., Brentjens, R.J. & Wolchok, J.D. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nature reviews Clinical oncology 13, 273 (2016). Cerca con Google

17. Cheung, A.S. & Mooney, D.J. Engineered materials for cancer immunotherapy. Nano today 10, 511-531 (2015). Cerca con Google

18. Park, J.A. & Cheung, N.-K.V. Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies. Cancer treatment reviews 58, 22-33 (2017). Cerca con Google

19. Finn, O.J. Cancer vaccines: between the idea and the reality. Nature Reviews Immunology 3, 630 (2003). Cerca con Google

20. Pardoll, D.M. Cancer vaccines. Nature medicine 4, 525 (1998). Cerca con Google

21. Butterfield, L.H. Cancer vaccines. Bmj 350, h988 (2015). Cerca con Google

22. Kantoff, P.W., et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New England Journal of Medicine 363, 411-422 (2010). Cerca con Google

23. Banchereau, J. & Palucka, K. Immunotherapy: Cancer vaccines on the move. Nature reviews Clinical oncology 15, 9 (2018). Cerca con Google

24. Sahin, U., et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222 (2017). Cerca con Google

25. Mitomo, K., et al. Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes. Molecular Therapy 18, 1173-1182 (2010). Cerca con Google

26. Lozier, J. Gene therapy of the hemophilias. in Seminars in hematology, Vol. 41 287-296 (Elsevier, 2004). Cerca con Google

27. Dellorusso, C., et al. Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proceedings of the National Academy of Sciences 99, 12979-12984 (2002). Cerca con Google

28. Cavazzana-Calvo, M., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672 (2000). Cerca con Google

29. Ginn, S.L., Amaya, A.K., Alexander, I.E., Edelstein, M. & Abedi, M.R. Gene therapy clinical trials worldwide to 2017: An update. The journal of gene medicine 20, e3015 (2018). Cerca con Google

30. Pezzoli, D. & Candiani, G. Non-viral gene delivery strategies for gene therapy: a “ménage à trois” among nucleic acids, materials, and the biological environment. Journal of nanoparticle research 15, 1523 (2013). Cerca con Google

31. Weide, B., Garbe, C., Rammensee, H.-G. & Pascolo, S. Plasmid DNA-and messenger RNA-based anti-cancer vaccination. Immunology letters 115, 33-42 (2008). Cerca con Google

32. Stewart, M.P., et al. In vitro and ex vivo strategies for intracellular delivery. Nature 538, 183 (2016). Cerca con Google

33. James, E.N., Ulery, B.D. & Nair, L.S. Biomaterials for Therapeutic Gene Delivery. Biomaterials Science: Processing, Properties and Applications II: Ceramic Transactions 237, 191-211 (2012). Cerca con Google

34. Bao, S., Thrall, B.D. & Miller, D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound in medicine & biology 23, 953-959 (1997). Cerca con Google

35. Lehrman, S. Virus treatment questioned after gene therapy death. (Nature Publishing Group, 1999). Cerca con Google

36. Islam, M.A., et al. Biomaterials for mRNA delivery. Biomaterials science 3, 1519-1533 (2015). Cerca con Google

37. Jorritsma, S., Gowans, E., Grubor-Bauk, B. & Wijesundara, D. Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines. Vaccine 34, 5488-5494 (2016). Cerca con Google

38. Xu, Y. & Szoka, F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35, 5616-5623 (1996). Cerca con Google

39. Zuhorn, I.S., et al. Nonbilayer phase of lipoplex–membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Molecular therapy 11, 801-810 (2005). Cerca con Google

40. Cornelis, S., Vandenbranden, M., Ruysschaert, J.-M. & Elouahabi, A. Role of intracellular cationic liposome–DNA complex dissociation in transfection mediated by cationic lipids. DNA and cell biology 21, 91-97 (2002). Cerca con Google

41. Hassett, K.J., et al. Optimization of lipid nanoparticles for intramuscular administration of mrna vaccines. Molecular Therapy-Nucleic Acids 15, 1-11 (2019). Cerca con Google

42. Hattori, Y., Kawakami, S., Nakamura, K., Yamashita, F. & Hashida, M. Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route. Journal of Pharmacology and Experimental Therapeutics 318, 828-834 (2006). Cerca con Google

43. De Smedt, S.C., Demeester, J. & Hennink, W.E. Cationic polymer based gene delivery systems. Pharmaceutical research 17, 113-126 (2000). Cerca con Google

44. Farber, F.E., Melnick, J.L. & Butel, J.S. Optimal conditions for uptake of exogenous DNA by Chinese hamster lung cells deficient in hypoxanthine-guanine phosphoribosyltransferase. Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein Synthesis 390, 298-311 (1975). Cerca con Google

45. Wu, G.Y. & Wu, C.H. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. Journal of Biological Chemistry 262, 4429-4432 (1987). Cerca con Google

46. Tietz, P.S., Yamazaki, K. & Larusso, N.F. Time-dependent effects of chloroquine on pH of hepatocyte lysosomes. Biochemical pharmacology 40, 1419-1421 (1990). Cerca con Google

47. Itaka, K., et al. In situ single cell observation by fluorescence resonance energy transfer reveals fast intra‐cytoplasmic delivery and easy release of plasmid DNA complexed with linear polyethylenimine. The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 6, 76-84 (2004). Cerca con Google

48. Thomas, M. & Klibanov, A.M. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proceedings of the National Academy of Sciences 99, 14640-14645 (2002). Cerca con Google

49. Ogris, M., Brunner, S., Schüller, S., Kircheis, R. & Wagner, E. PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene therapy 6, 595 (1999). Cerca con Google

50. Lee, C.C., MacKay, J.A., Fréchet, J.M. & Szoka, F.C. Designing dendrimers for biological applications. Nature biotechnology 23, 1517 (2005). Cerca con Google

51. Pack, D.W., Hoffman, A.S., Pun, S. & Stayton, P.S. Design and development of polymers for gene delivery. Nature reviews Drug discovery 4, 581 (2005). Cerca con Google

52. Borchard, G. Chitosans for gene delivery. Advanced drug delivery reviews 52, 145-150 (2001). Cerca con Google

53. Forrest, M.L., Koerber, J.T. & Pack, D.W. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate chemistry 14, 934-940 (2003). Cerca con Google

54. Gosselin, M.A., Guo, W. & Lee, R.J. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate chemistry 12, 989-994 (2001). Cerca con Google

55. Zhou, X., et al. Controlled release of PEI/DNA complexes from mannose-bearing chitosan microspheres as a potent delivery system to enhance immune response to HBV DNA vaccine. Journal of Controlled Release 121, 200-207 (2007). Cerca con Google

56. He, C., Hu, Y., Yin, L., Tang, C. & Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31, 3657-3666 (2010). Cerca con Google

57. Khalil, I.A., Kogure, K., Akita, H. & Harashima, H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacological reviews 58, 32-45 (2006). Cerca con Google

58. Bettinger, T., Remy, J.-S. & Erbacher, P. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjugate chemistry 10, 558-561 (1999). Cerca con Google

59. Zatloukal, K., et al. Transferrinfection. A Highly Efficient Way to Express Gene Constructs in Eukaryotic Cells. Annals of the New York Academy of Sciences, 136-153 (1992). Cerca con Google

60. Akinc, A., Thomas, M., Klibanov, A.M. & Langer, R. Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis. The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 7, 657-663 (2005). Cerca con Google

61. Li, W., Nicol, F. & Szoka Jr, F.C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Advanced drug delivery reviews 56, 967-985 (2004). Cerca con Google

62. Bremner, K.H., Seymour, L.W., Logan, A. & Read, M.L. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjugate chemistry 15, 152-161 (2004). Cerca con Google

63. Wong, S.Y., Pelet, J.M. & Putnam, D. Polymer systems for gene delivery—past, present, and future. Progress in Polymer Science 32, 799-837 (2007). Cerca con Google

64. Sève, A.-P., et al. Analysis of sugar-binding sites in mammalian cell nuclei by quantitative flow microfluorometry. Proceedings of the National Academy of Sciences 83, 5997-6001 (1986). Cerca con Google

65. Roche, A., et al. Glycofection: facilitated gene transfer by cationic glycopolymers. Cellular and Molecular Life Sciences CMLS 60, 288-297 (2003). Cerca con Google

66. Kim, T.-i., Ou, M., Lee, M. & Kim, S.W. Arginine-grafted bioreducible poly (disulfide amine) for gene delivery systems. Biomaterials 30, 658-664 (2009). Cerca con Google

67. Huang, K., Voss, B., Kumar, D., Hamm, H.E. & Harth, E. Dendritic molecular transporters provide control of delivery to intracellular compartments. Bioconjugate chemistry 18, 403-409 (2007). Cerca con Google

68. Stahl, P.D. & Ezekowitz, R.A.B. The mannose receptor is a pattern recognition receptor involved in host defense. Current opinion in immunology 10, 50-55 (1998). Cerca con Google

69. Boskovic, J., et al. Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor. Journal of Biological Chemistry 281, 8780-8787 (2006). Cerca con Google

70. Martinez-Pomares, L. The homeostatic properties of the mannose receptor in health and disease. Inmunología 27, 132-140 (2008). Cerca con Google

71. Gody, G., Maschmeyer, T., Zetterlund, P.B. & Perrier, S.b. Pushing the limit of the RAFT process: multiblock copolymers by one-pot rapid multiple chain extensions at full monomer conversion. Macromolecules 47, 3451-3460 (2014). Cerca con Google

72. Chiefari, J., et al. Living free-radical polymerization by reversible addition− fragmentation chain transfer: the RAFT process. Macromolecules 31, 5559-5562 (1998). Cerca con Google

73. Moad, G., Rizzardo, E. & Thang, S.H. Living radical polymerization by the RAFT process. Australian journal of chemistry 58, 379-410 (2005). Cerca con Google

74. Gody, G., Maschmeyer, T., Zetterlund, P.B. & Perrier, S. Rapid and quantitative one-pot synthesis of sequence-controlled polymers by radical polymerization. Nature communications 4, 2505 (2013). Cerca con Google

75. Sandler, S.R., Karo, W., Bonesteel, J. & Pearce, E.M. Polymer synthesis and characterization: a laboratory manual, (Elsevier, 1998). Cerca con Google

76. Truong, N.P., Dussert, M.V., Whittaker, M.R., Quinn, J.F. & Davis, T.P. Rapid synthesis of ultrahigh molecular weight and low polydispersity polystyrene diblock copolymers by RAFT-mediated emulsion polymerization. Polymer Chemistry 6, 3865-3874 (2015). Cerca con Google

77. Obata, M., et al. Synthesis, characterization and cellular internalization of poly(2-hydroxyethyl methacrylate) bearing α-d-mannopyranose. Polymer Chemistry 2, 651-658 (2011). Cerca con Google

78. Mattias Algotsson, P.B., Nicolas Thevenin. Method for synthesis of acrylamide derivatives. in United States Patent, Vol. US 7,294,743 B2 4 (GE Healthcare Bio-Sciences AB, United States, 2007). Cerca con Google

79. Evans, B.C., et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. JoVE (Journal of Visualized Experiments), e50166 (2013). Cerca con Google

80. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods 65, 55-63 (1983). Cerca con Google

81. Ghadban, A., Reynaud, E., Rinaudo, M. & Albertin, L. RAFT copolymerization of alginate-derived macromonomers–synthesis of a well-defined poly (HEMAm)-graft-(1→ 4)-α-l-guluronan copolymer capable of ionotropic gelation. Polymer Chemistry 4, 4578-4583 (2013). Cerca con Google

82. Lächelt, U. & Wagner, E. Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chemical reviews 115, 11043-11078 (2015). Cerca con Google

83. Pissuwan, D., Boyer, C., Gunasekaran, K., Davis, T.P. & Bulmus, V. In vitro cytotoxicity of RAFT polymers. Biomacromolecules 11, 412-420 (2010). Cerca con Google

84. Espuelas, S., Thumann, C., Heurtault, B., Schuber, F. & Frisch, B. Influence of ligand valency on the targeting of immature human dendritic cells by mannosylated liposomes. Bioconjugate chemistry 19, 2385-2393 (2008). Cerca con Google

85. Raviv, L., Jaron-Mendelson, M. & David, A. Mannosylated polyion complexes for in vivo gene delivery into CD11c+ dendritic cells. Molecular pharmaceutics 12, 453-462 (2015). Cerca con Google

86. Valdebenito, A. & Encinas, M.V. Effect of solvent on the free radical polymerization of N, N‐dimethylacrylamide. Polymer International 59, 1246-1251 (2010). Cerca con Google

87. Jiang, X., et al. Molar-mass characterization of cationic polymers for gene delivery by aqueous size-exclusion chromatography. Pharmaceutical research 23, 595-603 (2006). Cerca con Google

88. Blakney, A.K., Yilmaz, G., McKay, P.F., Becer, C.R. & Shattock, R.J. One size does not fit all: The effect of chain length and charge density of poly (ethylene imine) based copolymers on delivery of pDNA, mRNA, and RepRNA polyplexes. Biomacromolecules 19, 2870-2879 (2018). Cerca con Google

89. Engelberg, H. & Dudley, A. Plasma heparin levels in normal man. Circulation 23, 578-581 (1961). Cerca con Google

90. Manolova, V., et al. Nanoparticles target distinct dendritic cell populations according to their size. European journal of immunology 38, 1404-1413 (2008). Cerca con Google

91. Golan, R., Pietrasanta, L.I., Hsieh, W. & Hansma, H.G. DNA toroids: stages in condensation. Biochemistry 38, 14069-14076 (1999). Cerca con Google

92. Osada, K. Versatile DNA folding structures organized by cationic block copolymers. Polymer Journal, 1 (2019). Cerca con Google

93. Kwoh, D.Y., et al. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1444, 171-190 (1999). Cerca con Google

94. Li, Y., et al. Toroidal packaging of pDNA into block ionomer micelles exerting promoted in vivo gene expression. Biomacromolecules 16, 2664-2671 (2015). Cerca con Google

95. Filice, M. & Ruiz-Cabello, J. Nucleic Acid Nanotheranostics: Biomedical Applications, (Elsevier, 2019). Cerca con Google

96. Funhoff, A.M., et al. Endosomal escape of polymeric gene delivery complexes is not always enhanced by polymers buffering at low pH. Biomacromolecules 5, 32-39 (2004). Cerca con Google

97. Adolph, E.J., et al. Enhanced performance of plasmid DNA polyplexes stabilized by a combination of core hydrophobicity and surface PEGylation. Journal of Materials Chemistry B 2, 8154-8164 (2014). Cerca con Google

98. Behzadi, S., et al. Cellular uptake of nanoparticles: journey inside the cell. Chemical Society Reviews 46, 4218-4244 (2017). Cerca con Google

99. Biessen, E.A., et al. Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. Journal of Biological Chemistry 271, 28024-28030 (1996). Cerca con Google

100. Martens, T.F., Remaut, K., Demeester, J., De Smedt, S.C. & Braeckmans, K. Intracellular delivery of nanomaterials: how to catch endosomal escape in the act. Nano Today 9, 344-364 (2014). Cerca con Google

101. Karpova, T., et al. Fluorescence resonance energy transfer from cyan to yellow fluorescent protein detected by acceptor photobleaching using confocal microscopy and a single laser. Journal of microscopy 209, 56-70 (2003). Cerca con Google

102. Osada, K., et al. Quantized folding of plasmid DNA condensed with block catiomer into characteristic rod structures promoting transgene efficacy. Journal of the American Chemical Society 132, 12343-12348 (2010). Cerca con Google

103. Irvine, A.S., et al. Efficient nonviral transfection of dendritic cells and their use for in vivo immunization. Nature biotechnology 18, 1273 (2000). Cerca con Google

104. Awasthi, S. & Cox, R.A. Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent. Biotechniques 35, 600-604 (2003). Cerca con Google

105. Alegre, M.-L., Frauwirth, K.A. & Thompson, C.B. T-cell regulation by CD28 and CTLA-4. Nature Reviews Immunology 1, 220 (2001). Cerca con Google

106. Chen, J., et al. Charge-conversional zwitterionic copolymer as pH-sensitive shielding system for effective tumor treatment. Acta biomaterialia 26, 45-53 (2015). Cerca con Google

107. Kasturi, S.P., et al. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. Journal of Controlled Release 113, 261-270 (2006). Cerca con Google

108. Ma, Y.-F. & Yang, Y.-W. Delivery of DNA-based cancer vaccine with polyethylenimine. European Journal of Pharmaceutical Sciences 40, 75-83 (2010). Cerca con Google

109. Velluto, D., Thomas, S.N., Simeoni, E., Swartz, M.A. & Hubbell, J.A. PEG-b-PPS-b-PEI micelles and PEG-b-PPS/PEG-b-PPS-b-PEI mixed micelles as non-viral vectors for plasmid DNA: tumor immunotoxicity in B16F10 melanoma. Biomaterials 32, 9839-9847 (2011). Cerca con Google

110. Overwijk, W.W. & Restifo, N.P. B16 as a mouse model for human melanoma. Current protocols in immunology 39, 20.21. 21-20.21. 29 (2000). Cerca con Google

Solo per lo Staff dell Archivio: Modifica questo record